Jazz Pharmaceuticals (JAZZ) PT Lowered to $190 at B.Riley/FBR
Tweet
Share
E-mail
Get Alerts JAZZ Hot Sheet
Price: $243.84 +0.10%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 43
Join SI Premium – FREE
B.Riley/FBR analyst David Buck lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $190.00 (from $219.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$236 at Bernstein SocGen Group
- J.B. Hunt Transport Services (JBHT) PT Lowered to $264 at UBS on Cost Pressures
- Sirius XM Radio (SIRI) PT Raised to $37 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
David BuckSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
